Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
In our rare disease trial strategies whitepaper, see which sponsors lead the way, understand the geographical location of trials, and delve into the types of therapeutic area, plus much more.
Read MoreIn this infographic, data from our industry-leading Citeline intelligence sources and patient insights from an Informa-Rare Patient Voice survey lay the groundwork for a set of strategic recommendations sponsors can implement to optimize rare disease clinical trials.
View InfographicLearn more about our suite of solutions providing the industry’s most comprehensive, reliable, and up-to-date global R&D intelligence.
Request a demoThe industry’s only all-in-one clinical trial recruitment platform that accelerates trial enrollment via innovative technology and services allowing you to educate, recruit and enroll in a pay-for-performance model.
Design on time and on budget trials with the world’s most comprehensive, up-to-date, and trusted source of pharmaceutical clinical trial data and intelligence.
A Pharmaprojects Use Case
Given the additional challenges impacting rare disease R&D, the ability to easily generate critical insights and hone your development strategy is key. Our use case shows how you can effectively assess the rare disease landscape.
Read MoreCiteline Engage provides targeted support to enhance study planning, design, feasibility and trial awareness.
Our robust global network of healthcare providers spans multiple therapeutic areas with real-world patient data enhancing identification and targeting strategies.
Download flyerLearn more about our suite of solutions providing the industry’s most comprehensive, reliable, and up-to-date global R&D intelligence.
Request a demo